U.S. markets closed
  • S&P Futures

    4,153.75
    -29.75 (-0.71%)
     
  • Dow Futures

    34,539.00
    -129.00 (-0.37%)
     
  • Nasdaq Futures

    13,188.50
    -168.25 (-1.26%)
     
  • Russell 2000 Futures

    2,179.20
    -30.40 (-1.38%)
     
  • Crude Oil

    64.59
    -0.33 (-0.51%)
     
  • Gold

    1,838.20
    +0.60 (+0.03%)
     
  • Silver

    27.44
    -0.05 (-0.19%)
     
  • EUR/USD

    1.2140
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • Vix

    19.66
    +2.97 (+17.80%)
     
  • GBP/USD

    1.4119
    -0.0002 (-0.02%)
     
  • USD/JPY

    108.9030
    +0.0620 (+0.06%)
     
  • BTC-USD

    55,652.42
    -3,258.93 (-5.53%)
     
  • CMC Crypto 200

    1,466.07
    -95.23 (-6.10%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    28,835.86
    -682.48 (-2.31%)
     

Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

NEW YORK, Jan 30 (Reuters) - Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly & Co, were named in a class action lawsuit about price fixing filed by a group of patients.

The suit, filed in a federal court in Massachusetts, says that the companies during the past five years have simultaneously hiked the price of insulin by over 150 percent.

(Reporting by Caroline Humer; Editing by Sandra Maler)